Sluggish Parexel could be poised for a long-term turnaround

Parexel International ($PRXL) startled investors last quarter when its net new business dropped 30% from the previous three months. But, as The Motley Fool points out, the CRO giant is well-positioned in a growing industry, and sales are likely to rebound. Article